BCL6 and chronic myelogenous leukemia, BCR-ABL1 positive: It was reported that BCL6 is associated with tyrosine kinase inhibitors (TKI) resistance in Philadelphia chromosome positive (Ph+) ALL and chronic myeloid leukemia (CML) cells [27, 28].